Emotion Regulation in Binge Eating and Purging Among Adolescents

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03429114
Collaborator
(none)
60
1
57.5
1

Study Details

Study Description

Brief Summary

The study will examine the neural and behavioral correlates of emotion regulation in adolescents engaging in binge eating and/or purging and healthy adolescents. Furthermore, it will look at the influence of executive function on emotion regulation in this population. This study will allow us to gain further understanding of the neural basis of emotion regulation in this age group. Moreover, this study supports the need to develop new treatment approaches based on a better understanding of the brain processes associated with eating disorders.

Condition or Disease Intervention/Treatment Phase
  • Other: Magnetic resonance imaging

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Neural Correlates of Emotion Regulation and Executive Function in Binge Eating and Purging Among Adolescents
Actual Study Start Date :
Oct 15, 2017
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Binge eating/purging

Adolescents engaging in recurrent binge eating and/or purging behavior.

Other: Magnetic resonance imaging
We will conduct MRI and fMRI brain scans to compare brain function between groups.

Healthy comparison

Adolescents who do not have a history of eating disorders

Other: Magnetic resonance imaging
We will conduct MRI and fMRI brain scans to compare brain function between groups.

Outcome Measures

Primary Outcome Measures

  1. Brain activity during emotion conflict [Baseline]

    Functional magnetic resonance imaging will be used to measure brain activity during a task where participants respond to images of faces with emotional expressions overlaid with an emotion word written in text. We will focus on brain response during this task when emotion face vs word are in conflict.

  2. Brain activity during emotion regulation [Baseline]

    Functional magnetic resonance imaging will be used to measure brain activity during a task where participants attempt to regulate emotional responses.

  3. Brain activity during cognitive control and emotion response [Baseline]

    Functional magnetic resonance imaging will be used to measure brain activity during a task where participants engage in cognitive control and respond to emotional stimuli.

Secondary Outcome Measures

  1. Behavioral performance on emotion conflict task [Baseline]

    Response times will be used as behavioral measure on the emotion conflict task

  2. Behavioral performance on emotion regulation task [Baseline]

    Emotion ratings will be used as behavioral measure on the emotion regulation task

  3. Behavioral performance on cognitive control and emotion regulation task [Baseline]

    Emotion ratings will be used as behavioral measure on the cognitive control and emotion regulation task

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 18 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female

  • Ages 14-18

  • with or without current binge eating and/or purging behaviors

Exclusion Criteria:

We exclude patients of clinically significant low weight (<85% ideal body weight using CDC norms for height, age, and gender) and those with contraindications for MRI (e.g., orthodontia, metallic implants). Participants also will be without evidence of current or past major neurological (e.g., seizures, psychosis, head trauma) or major sensory deficit.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University, Department of Psychiatry Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cara Bohon, PhD, Assistant Professo, Stanford University
ClinicalTrials.gov Identifier:
NCT03429114
Other Study ID Numbers:
  • 40075
First Posted:
Feb 12, 2018
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 9, 2022